Back to PFE Stock Lookup

Pfizer (PFE) – Press Releases

Jul 31, 2014 04:30 PM Zoetis Declares Third Quarter 2014 Dividend
Jul 30, 2014 10:33 AM InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada
Jul 30, 2014 08:00 AM Pfizer Enters Into Agreement to Acquire Baxter’s Portfolio of Marketed Vaccines
Jul 29, 2014 07:00 AM European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
Jul 29, 2014 07:00 AM PFIZER REPORTS SECOND-QUARTER 2014 RESULTS
Jul 17, 2014 08:06 AM Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion
Jul 16, 2014 10:00 AM #FOGO? – New Survey Reveals 87% of Americans have a Fear of Getting Old (FOGO) – Results Show Top Fear is Decline in Physical Ability1
Jul 16, 2014 09:26 AM Pfizer to Acquire InnoPharma, Inc.
Jul 16, 2014 07:00 AM Pfizer Announces Positive Top-Line Results From Phase 3 Study Of NONACOG ALFA (BeneFIX®) Once-Weekly Prophylaxis For Hemophilia B
Jun 27, 2014 07:00 AM Eliquis® (apixaban) Receives CHMP Positive Opinion for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
Jun 26, 2014 11:20 AM Pfizer Declares 26-Cent Third-Quarter 2014 Dividend
Jun 26, 2014 09:45 AM James C. Smith Elected to Pfizer’s Board of Directors
Jun 24, 2014 10:00 AM Pfizer Invites Public to View and Listen to Webcast of July 29 Conference Call with Analysts
Jun 18, 2014 05:01 PM Two-Year Results From Pfizer’s XELJANZ® (Tofacitinib Citrate) ORAL Start Study Published in The New England Journal of Medicine
Jun 18, 2014 01:00 AM Pfizer And Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration
Jun 17, 2014 08:00 AM Pfizer Announces Submission of Biologics License Application to the FDA for Investigational Meningococcal B Vaccine
Jun 16, 2014 01:55 PM Xybion Announces Pristima Selected by Pfizer Inc. for its Drug Safety R&D Data Management Solution
Jun 16, 2014 08:00 AM Pfizer Opens New State-of-the-Art Research and Development Site in Cambridge, Massachusetts
Jun 12, 2014 06:17 AM ViiV Healthcare announces new collaboration with Janssen to investigate single-tablet regimen for maintenance treatment of HIV-1
Jun 11, 2014 08:00 AM Pfizer Announces Over 10 Abstracts for XELJANZ® (Tofacitinib Citrate) in Rheumatoid Arthritis to be Presented at the European League Against Rheumatism (EULAR) 2014 Annual Meeting
Jun 10, 2014 07:00 AM National Survey Identifies Potential Barriers to HIV Treatment Use in U.S.
Jun 4, 2014 10:00 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Jun 4, 2014 06:00 AM KineMed Collaboration with Pfizer Inc. in Diabetes is Extended
May 29, 2014 11:14 AM Dr. Morris J. Birnbaum Joins Pfizer as Chief Scientific Officer, Cardiovascular and Metabolic Disease Research
May 29, 2014 08:30 AM Retrophin Names Alvin Shih, M.D. Executive Vice President of Research and Development
May 29, 2014 08:00 AM Pfizer and the Avon Foundation for Women Announce $1 Million Grants Program to Address Gaps in Support for People Living with Metastatic Breast Cancer
May 28, 2014 08:00 AM Nodality, Inc. Announces Publication of Promising Data in Melanoma in Journal of Translational Medicine
May 27, 2014 08:30 AM Pfizer Brings Frequent Heartburn Relief Over-the-Counter with New Nexium® 24HR
May 26, 2014 10:05 AM Statement from Pfizer Inc.
May 23, 2014 09:13 AM Pfizer Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis
May 21, 2014 08:15 AM New Survey Highlights The Impact Of Menopausal Symptoms On Women In The Workplace
May 20, 2014 04:00 PM GlycoMimetics Receives $15 Million Payment from Pfizer in Connection with Planned Initiation of Phase 3 Trial
May 19, 2014 06:41 PM Statement from Pfizer Inc.
May 19, 2014 08:30 AM Senesco Completes Acquisition of Fabrus
May 19, 2014 08:05 AM Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
May 19, 2014 08:05 AM Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
May 18, 2014 05:03 PM Pfizer Makes Final Proposal to AstraZeneca
May 16, 2014 12:12 PM Pfizer To Submit Palbociclib New Drug Application With FDA Based On Final Results Of PALOMA-1
May 15, 2014 11:27 AM American College of Physicians, CECity, and Pfizer collaborate to increase adult immunization rates
May 13, 2014 02:05 AM Pfizer’s Possible Offer for AstraZeneca plc (“AstraZeneca”) Represents Compelling Shareholder Value
May 12, 2014 06:49 PM Pfizer Prices $4.5 Billion Debt Offering
May 12, 2014 10:39 AM RiverVest Venture Partners’ Portfolio Company Lumena is Sold to Shire for $260 million; Represents Sixth Exit from RiverVest Venture Fund II
May 9, 2014 10:30 AM Pfizer Announces Positive Phase 2 Study Results for Investigational Meningococcal B Vaccine
May 6, 2014 08:30 AM Pain Therapeutics Reports Q1 2014 Financial Results
May 5, 2014 07:30 AM Lpath Lands Fast-Track SBIR Grant from the NIH for Traumatic Brain Injury Treatment
May 5, 2014 07:00 AM PFIZER REPORTS FIRST-QUARTER 2014 RESULTS
Jan 13, 2014 08:00 AM Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With

Back to PFE Stock Lookup